{"url_path":"/sec/biafw/8-k/2026-06-02/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1712762/0001493152-26-026773-index.html","accession_number":"0001493152-26-026773","cik":"0001712762","ticker":"BIAF","issuer_name":"bioAffinity Technologies, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1712762/0001493152-26-026773-index.html","primary_entity_key":"0001712762","primary_entity_name":"bioAffinity Technologies, Inc."},"word_count":68,"has_tables":true,"body_markdown":"**Item\n8.01. Other Events.**\n\n \n\nOn\nJune 2, 2026, bioAffinity Technologies, Inc., a Delaware corporation, issued a press release announcing that the Society for Advanced\nBronchoscopy (SAB) will host a webinar on CyPath® Lung’s expanding role in pulmonary, oncology and surgical practices in the\ndetection and management of early-stage lung cancer.\n\n \n\nA\ncopy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference."}